通过CDK12介导的FOXA1酸化通过MDM2-p53轴促进前列腺癌的进展
Binyuan Yan1,2, Mengjun Huang1, Jinxiang Wang1
1Department of Urology, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
Research (Washington, D.C.)
|December 15, 2025
概括
研究人员发现了一种推动前列腺癌 (PCa) 进展的新途径,涉及循环素依赖激酶12 (CDK12) 和分叉盒A1 (FOXA1) 酸化. 针对这一轴为PCa提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 前列腺癌 (PCa) 的进展涉及复杂的分子信号和蛋白质修饰.
- 了解新的调节途径对于开发有效的PCa治疗至关重要.
研究的目的:
- 确定和描述前列腺癌中一种新的致癌途径.
- 调查环林依赖激酶12 (CDK12) 在调节分叉盒A1 (FOXA1) 活动中的作用.
- 探索针对这个新发现的途径的治疗策略.
主要方法:
- 研究了FOXA1通过CDK12的相互作用和酸化.
- 分析了对MDM2和p53.5的下游影响.
- 利用小分子抑制剂 (THZ531) 和RNA干扰用于治疗向.
- 对PCa细胞存活,增殖和亡的评估影响.
主要成果:
- 在S234中识别的CDK12介导的FOXA1酸化增强了其转录活性.
- 这个轴对MDM2进行上调,导致p53的不稳定,并促进PCa细胞的存活.
- 用THZ531或RNAi向CDK12,恢复了p53的稳定性并诱导了亡,抑制了瘤的生长.
结论:
- CDK12-FOXA1-MDM2轴是前列腺癌进展的关键驱动因素.
- 向FOXA1酸化是PCa的一种有前途的治疗策略.
- 这项研究为针对PCa的精密疗法提供了机制基础.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K


